home About Us People Portfolio Contact Us Fund II Investor Login » Fund III Investor Login » Fund IV Investor Login » Fund V Investor Log In »

TriVascular

$96 million

Medical Device
Cardiovascular

TriVascular is a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. TriVascular manufactures the Ovation Abdominal Stent Graft platform, the lowest profile FDA-approved endovascular aortic repair (EVAR) system, which utilizes a novel, polymer-based sealing mechanism. TriVascular is based in Santa Rosa, California.